Emily Olsen

In a preview of their HIMSS22 presentation, Robert Jarrin, strategic advisor to ResMed Corp., and Brian Scarpelli, senior global policy counsel at the Connected Health Initiative, explain the current digital health reimbursement landscape.

Cofounder and CEO Matthew Stoudt discusses AppliedVR's De Novo clearance from November, what's next for the company and the biggest trends from 2021.

Also: Truepill launches a COVID-19 test coverage platform for insurers, and 23andMe extends its partnership with GSK.

The deal adds to Dario's musculoskeletal care offerings. It launched its Dario Move platform in October.

Also: Topography Health launches out of stealth with $27.5 million, Mantra Health raises $22 million and NuvoAir announces an $11 million extension.

The study, sponsored by digital musculoskeletal-care company SWORD Health, also found improvements in secondary measures like surgery intent and painkiller use.

Also: German startup Wellster Healthtech brings its Series B raise to $60 million, Faeth Therapeutics scoops up $20 million and Yuvo Health announces a $7.3 million seed round.

The male and female hormone tests are the first product in the company's Kind at Home consumer products division.

The startup leverages blockchain and FHIR technologies to allow for secure data exchange between healthcare organizations.

The class action lawsuit alleges a proxy statement provided to investors before the merger misrepresented the company's financial performance and prospects.